Literature DB >> 32258556

Regulation of colonic epithelial butyrate transport: Focus on colorectal cancer.

Pedro Gonçalves1, Fátima Martel2.   

Abstract

HIGHLIGHTS: Fermentation of the dietary fiber by intestinal microflora results in production of butyrate.Butyrate possesses anticarcinogenic effect at the colonic level.Three transporters (MCT1, SMCT1 and BCRP) regulate the intracellular concentration of BT in colonic epithelial cells.Changes in the expression of these transporters occur in colorectal cancer. ABSTRACT: Colorectal cancer (CRC) is one of the most common solid tumors worldwide. Consumption of dietary fiber is associated with a low risk of developing CRC. The fermentation of the dietary fiber by intestinal microflora results in production of butyrate (BT). This short-chain fatty acid is an important metabolic substrate in normal colonic epithelial cells and has important homeostatic functions at the colonic level. Because the cellular effects of BT (e.g. inhibition of histone deacetylases) are dependent on its intracellular concentration, knowledge on the mechanisms involved in BT membrane transport and its regulation seems particularly relevant. In this review, we will present the carrier-mediated mechanisms involved in BT membrane transport at the colonic epithelial level and their regulation, with an emphasis on CRC. Several xenobiotics known to modulate the risk for developing CRC are able to interfere with BT transport at the intestinal level. Thus, interference with BT transport certainly contributes to the anticarcinogenic or procarcinogenic effect of these compounds and these compounds may interfere with the anticarcinogenic effect of BT. Finally, we suggest that differences in BT transport between normal colonocytes and tumoral cells contribute to the "BT paradox" (the apparent opposing effect of BT in CRC cells and normal colonocytes). Copyright 2016 PBJ-Associação Porto Biomedical/Porto Biomedical Society.

Entities:  

Keywords:  BCRP; Butyrate; Colorectal cancer; MCT1; SMCT1

Year:  2016        PMID: 32258556      PMCID: PMC6806744          DOI: 10.1016/j.pbj.2016.04.004

Source DB:  PubMed          Journal:  Porto Biomed J        ISSN: 2444-8664


  189 in total

Review 1.  Anticarcinogenic actions of tributyrin, a butyric acid prodrug.

Authors:  Renato Heidor; Juliana Festa Ortega; Aline de Conti; Thomas Prates Ong; Fernando Salvador Moreno
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

2.  Expression and membrane localization of MCT isoforms along the length of the human intestine.

Authors:  Ravinder K Gill; Seema Saksena; Waddah A Alrefai; Zaheer Sarwar; Jay L Goldstein; Robert E Carroll; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Am J Physiol Cell Physiol       Date:  2005-05-18       Impact factor: 4.249

3.  Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Adrian L Harris; Efthimios Sivridis
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

4.  The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma.

Authors:  Jun Fang; Quintin J Quinones; Trevor L Holman; Michael J Morowitz; Qun Wang; Huaqing Zhao; Frank Sivo; John M Maris; Miriam L Wahl
Journal:  Mol Pharmacol       Date:  2006-09-25       Impact factor: 4.436

5.  Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma.

Authors:  Sung Nam Kang; Eunmyong Lee; Mi-Kyung Lee; Soo-Jeong Lim
Journal:  Drug Deliv       Date:  2010-10-14       Impact factor: 6.419

Review 6.  Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.

Authors:  Serena Di Cosimo; Gianluigi Ferretti; Paola Papaldo; Paolo Carlini; Alessandra Fabi; Francesco Cognetti
Journal:  Drugs Today (Barc)       Date:  2003-03       Impact factor: 2.245

7.  Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma.

Authors:  Yoh Zen; Takahiko Fujii; Seiichi Yoshikawa; Hiroyuki Takamura; Takashi Tani; Tetsuo Ohta; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

8.  Monocarboxylate transporter (MCT)-1 is up-regulated by PPARalpha.

Authors:  Bettina König; Alexander Koch; Karen Giggel; Batsuch Dordschbal; Klaus Eder; Gabriele I Stangl
Journal:  Biochim Biophys Acta       Date:  2008-03-18

9.  Butyrate-induced alterations of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cells.

Authors:  R Kopp; M Fichter; R Assert; A F Pfeiffer; S Classen
Journal:  Int J Mol Med       Date:  2009-05       Impact factor: 4.101

10.  Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle.

Authors:  Marieangela C Wilson; David Meredith; Chotirote Bunnun; Richard B Sessions; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

View more
  5 in total

Review 1.  The effects of different dietary fiber pectin structures on the gastrointestinal immune barrier: impact via gut microbiota and direct effects on immune cells.

Authors:  Martin Beukema; Marijke M Faas; Paul de Vos
Journal:  Exp Mol Med       Date:  2020-09-10       Impact factor: 8.718

Review 2.  The Immunomodulatory Functions of Butyrate.

Authors:  Mohamed Tausif Siddiqui; Gail A M Cresci
Journal:  J Inflamm Res       Date:  2021-11-18

3.  Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation.

Authors:  Aurélien Trompette; Julie Pernot; Olaf Perdijk; Rayed Ali A Alqahtani; Jaime Santo Domingo; Dolores Camacho-Muñoz; Nicholas C Wong; Alexandra C Kendall; Andreas Wiederkehr; Laurent P Nicod; Anna Nicolaou; Christophe von Garnier; Niki D J Ubags; Benjamin J Marsland
Journal:  Mucosal Immunol       Date:  2022-06-07       Impact factor: 8.701

Review 4.  Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases.

Authors:  Naschla Gasaly; Marcela A Hermoso; Martín Gotteland
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

Review 5.  Biochemical and Metabolical Pathways Associated with Microbiota-Derived Butyrate in Colorectal Cancer and Omega-3 Fatty Acids Implications: A Narrative Review.

Authors:  Adelina Silvana Gheorghe; Șerban Mircea Negru; Mădălina Preda; Raluca Ioana Mihăilă; Isabela Anda Komporaly; Elena Adriana Dumitrescu; Cristian Virgil Lungulescu; Lidia Anca Kajanto; Bogdan Georgescu; Emanuel Alin Radu; Dana Lucia Stănculeanu
Journal:  Nutrients       Date:  2022-03-09       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.